BioLife Solutions Inc. (NASDAQ: BLFS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BIOLIFE SOLUTIONS INC.

BioLife Solutions Inc. (NASDAQ: BLFS)
Listen to this Section


$26.45
-0.6400 ( -2.36% ) 194.4K

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

Market Data


Open $26.45
Previous Close $27.09
Volume 194.4K
Market Cap $1.33B
Day Range $26.14 - $27.51
52 Week Range $17.86 - $29.62
Shares Outstanding 48.86M
Change % -2.36%
Net Change ▼ -0.6400
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryMedical Instruments & Supplies
IPO Year1989
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -21,511.00

Date Type Amount Purchased Purchaser
2024-07-03 Sale -3000.00 Aebersold Sarah
2024-06-18 Sale -10000.00 Berard Todd
2024-05-31 Sale -408.00 Foster Karen A.
2023-12-19 Sale -211.00 Phillips Geraint
2023-12-19 Sale -228.00 Foster Karen A.
2023-12-04 Sale -394.00 Aebersold Sarah
2023-12-04 Sale -234.00 Phillips Geraint
2023-12-04 Sale -394.00 Berard Todd
2023-12-04 Sale -298.00 Wichterman Troy
2023-12-04 Sale -826.00 Mathew Aby J.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Aug 07, 2025
10-q Quarterly Reports 106 Aug 07, 2025
4 Insider transactions 1 Jul 22, 2025
4 Insider transactions 1 Jul 09, 2025
4 Insider transactions 1 Jul 09, 2025
4 Insider transactions 1 Jul 09, 2025
4 Insider transactions 1 Jul 09, 2025
4 Insider transactions 1 Jul 09, 2025
def Proxies and info statements 20 Jul 08, 2025
4 Insider transactions 1 Jun 18, 2025

Latest News


× Before browsing our site, please accept our cookies policy